Latest Regulatory News

Page 566 of 628
Poseidon Nickel Limited’s shares have been suspended from trading following court approval of Horizon Minerals’ acquisition scheme, marking a pivotal step in the nickel miner’s corporate evolution.
Maxwell Dee
Maxwell Dee
10 Feb 2025
Auswide Bank Ltd's shares have been suspended from trading following court approval of its acquisition by MyState Bank Limited, marking a significant consolidation in the Australian retail banking sector.
Victor Sage
Victor Sage
10 Feb 2025
Foresta Group Holdings has signed a non-binding term sheet with Genesis Energy to supply torrefied wood pellets for Huntly Power Station, marking a pivotal step toward reducing New Zealand’s coal dependency by 2028.
Maxwell Dee
Maxwell Dee
10 Feb 2025
JPMorgan Asset Management has announced estimated cash distributions for its Global Equity Premium Income ETFs for February 2025, alongside a detailed timetable for investors to follow.
Claire Turing
Claire Turing
10 Feb 2025
Matsa Resources has advised shareholders to take no immediate action following Patronus Resources’ unsolicited takeover offer, with a formal recommendation expected soon.
Maxwell Dee
Maxwell Dee
10 Feb 2025
Gyder Surgical, backed by Hydrix Ventures, has secured FDA 510(k) clearance for its innovative GYDER Hip System, opening the door to the lucrative U.S. market and increasing Hydrix’s investment value.
Ada Torres
Ada Torres
10 Feb 2025
TEAMINVEST PRIVATE GROUP LIMITED has announced a fully franked ordinary dividend of AUD 0.015 per share for the six months ending December 31, 2024, payable in March 2025.
Claire Turing
Claire Turing
10 Feb 2025
Sarytogan Graphite Limited has received A$2.36 million from the EBRD as part of a second tranche equity investment, boosting the bank’s stake to 17.3%. An independent peer review affirms the project’s promise while highlighting manageable risks.
Maxwell Dee
Maxwell Dee
10 Feb 2025
Auswide Bank’s acquisition by MyState Bank has reached a key milestone with the scheme of arrangement now legally effective, triggering a suspension of Auswide’s shares and setting the stage for shareholder transitions.
Victor Sage
Victor Sage
10 Feb 2025
Alterity Therapeutics has raised A$40 million through a two-tranche placement to advance its lead compound ATH434 for neurodegenerative diseases, including Multiple System Atrophy and Parkinson's disease.
Ada Torres
Ada Torres
10 Feb 2025
KALINA Power has significantly expanded its land holdings in Alberta, boosting its potential Power-CCS capacity to 1.7 GW to meet surging demand for data centre power solutions with carbon capture.
Maxwell Dee
Maxwell Dee
10 Feb 2025
WAM Global reports a robust 23.7% increase in its investment portfolio for the year ending December 2024, prompting a rise in fully franked dividends including a special payout. The company’s strong financial results underscore its confidence in sustained growth and shareholder returns.
Claire Turing
Claire Turing
10 Feb 2025